Patent ID: 8642591
Filing Date: 2014-02-04
Classification: A61K,A61P

Abstract:
1. A composition comprising α-methyl prednisolone, or a salt thereof, and N 1 -[(3S)-2-hydroxytetrahydrofuran-3-yl]-N 2 -[imino(10H-phenothiazin-2-yl)methyl]-L-leucinamide, or a salt thereof, wherein the α-methyl prednisolone or a salt thereof and N 1 -[(3S)-2-hydroxytetrahydrofuran-3-yl]-N 2 -[imino(10H-phenothiazin-2-yl)methyl]-L-leucinamide or a salt thereof are present in a synergistically effective weight ratio of 1 part α-methyl prednisolone or a salt thereof to at least 0.1 parts N 1 -[(3S)-2-hydroxytetrahydrofuran-3-yl]-N 2 -[imino(10H-phenothiazin-2-yl)methyl]-L-leucinamide.